ETF Channel: Implied Analyst Target Price for IWO ETF is $369, with 20.18% Upside to Current Price

The iShares Russell 2000 Growth ETF (IWO) has an implied analyst target price of $368.56, which represents a 20.18% upside from its recent price of $306.67. Analysts see potential upside in holdings such as Contango Ore (CTGO), KORU Medical Systems (KRMD), and Sanuwave Health (SNWV), with average analyst target prices 38.76%, 31.46%, and 30.98% higher than their recent prices, respectively.

Analysts are optimistic about the iShares Russell 2000 Growth ETF (IWO), with an implied analyst target price of $368.56, representing a 20.18% upside from its recent price of $306.67. This positive outlook is driven by several key holdings within the ETF, including Contango Ore (CTGO), KORU Medical Systems (KRMD), and Sanuwave Health (SNWV).

Contango Ore, a leading provider of specialty chemicals, has seen analysts set an average target price 38.76% higher than its recent price, reflecting strong growth prospects. Similarly, KORU Medical Systems, a medical technology company, has an average analyst target price 31.46% above its recent price, indicating significant upside potential. Sanuwave Health, a company focused on intravascular shockwave applications, has an average analyst target price 30.98% higher than its recent price, driven by recent financial developments such as a $5M cash payment from a third-party licensee [1].

Sanuwave Health, in particular, has experienced a notable increase in stock price following the announcement of a $5M cash payment from a third-party licensee in connection with the exercise of a previously granted acquisition option. This payment is part of an exclusive license and option agreement, where the licensee paid a one-time licensing fee of $2.5M for the rights to utilize a portfolio of patents focused on intravascular shockwave applications. The stock has seen an 8% rise today, underscoring the positive market sentiment surrounding the company's financial performance [1].

These positive analyst assessments and recent financial developments suggest that the iShares Russell 2000 Growth ETF (IWO) is well-positioned for further growth. Investors should closely monitor the performance of these key holdings and the broader market trends to make informed investment decisions.

References:
[1] https://seekingalpha.com/news/4488440-sanuwave-health-rises-after-5m-payment-related-to-patent-sale